TNDM Q1 2024 Earnings — Tandem Diabetes Care, Inc. Revenue & Financial Results | Market Cap Arena

TNDMTandem Diabetes Care, Inc.

$1B

Q1 2024 Earnings

Healthcare Medical - Devices

Income Statement

Revenue

$192M+13.2% YoY

Gross Profit

$95M49.4% margin

Operating Income

-$42M-21.7% margin

Net Income

-$43M-22.3% margin

EPS (Diluted)

$-0.65

QoQ Revenue Growth

-2.6%

Cash Flow

Operating Cash Flow

-$8M

Free Cash Flow

-$12M

Stock-Based Comp.

$22M

Balance Sheet

Total Assets

$941M

Total Liabilities

$698M

Stockholders' Equity

$243M

Cash & Equivalents

$59M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$192M	$169M	+13.2%
Gross Profit	$95M	$83M	+14.2%
Operating Income	-$42M	-$128M	+67.4%
Net Income	-$43M	-$124M	+65.5%

Revenue Segments

Supplies and Other

$106M55%

Pump

$87M45%

Geographic Segments

UNITED STATES

$130M68%

Non-US

$62M32%